| For: | Hao K, Paik AJ, Han LH, Makary MS. Yttrium-90 radioembolization treatment strategies for management of hepatocellular carcinoma. World J Radiol 2024; 16(10): 512-527 [PMID: 39494134 DOI: 10.4329/wjr.v16.i10.512] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v16/i10/512.htm |
| Number | Citing Articles |
| 1 |
Maryam Rahbaran, Shirin A Enger, Parminder S Basran. Dosimetric characterization of a 90Sr90Y Pterygium applicator with radiochromic film and Monte Carlo Simulations. Physics in Medicine & Biology 2025; 70(24) doi: 10.1088/1361-6560/ae24dc
|
| 2 |
Abdulmohsen Ahmed Alhussaini, Saleh AlShreadah, Mohamed Rajab Elzahrani, Abdulaziz AlTaweel, Mohammed AlAhmed, Omar Bashir, Shaker Al Shehri, Mohammad Arabi. Survival Outcomes in Hepatocellular Carcinoma Patients Undergoing TARE: A Comparative Analysis Before and After Single Admission Order–Map–Treat Protocol Implementation. Cancers 2025; 17(24) doi: 10.3390/cancers17243930
|
| 3 |
Tae Kyu Lee. Clinical Implementation of a Contour-Consistent Workflow for Activity Calculation and Post-Treatment SPECT/CT Dosimetry in Y-90 Glass Microsphere Radioembolization. Journal of Vascular and Interventional Radiology 2026; 37(9) doi: 10.1016/j.jvir.2026.108872
|
| 4 |
Faisal M. Sanai, Ahmed Saati, Hamdan Alghamdi, Saad Aldosari, Adnan Alzanbagi, Ali Albenmousa, Khalid I. Bzeizi, Faisal Abaalkhail, Bandar AlJudaibi, Saleh A. Alqahtani. Predictors and outcomes of hepatic decompensation following transarterial locoregional therapy in hepatocellular carcinoma. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-54466-4
|
| 5 |
Deepshekhar Gupta, Yunjuan Liu, Chris Miller-Rosales, Fangzhou Wei, Edward Tuttle, Ekaterina Byers, Richard Marshak, Richard Marshall. Clinical outcomes of pressure-enabled drug delivery for trans-arterial chemoembolization and radioembolization. Journal of Comparative Effectiveness Research 2026; 15(5) doi: 10.57264/cer-2025-0144
|
| 6 |
Qianwen Ni, Kenan Wang, Wenyi Jin, Yakun Gao, Ping Gong, Zhenguang Wang, Zheqi Xu, Hui Liu, Susu Luo. Global landscape of yttrium-90 clinical trials: a systematic registry-based analysis. Trials 2026; 27(1) doi: 10.1186/s13063-026-09659-7
|
| 7 |
Ramanpreet Singh, Mina S. Makary. Locoregional Therapies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Journal of Gastrointestinal Cancer 2025; 56(1) doi: 10.1007/s12029-025-01280-2
|
| 8 |
Yoselin Dos Santos Poleo, Abrahams Ocanto Martínez. Radioembolization for hepatocellular carcinoma. Revisiones en Cáncer 2025; doi: 10.20960/revcancer.00121
|
| 9 |
Role of emerging theranostic technologies in precision oncology: revolutionizing cancer diagnosis and treatment. Oncologie 2025; 27(2) doi: 10.1515/oncologie-2024-0543
|
| 10 |
Juana Valentina Barrera, Maria del Pilar Bayona Molano. Evolving Strategies in the Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Narrative Review of Locoregional and Surgical Therapies. Techniques in Vascular and Interventional Radiology 2025; 28(4) doi: 10.1016/j.tvir.2025.101081
|
| 11 |
Andrey G. Kazakov, Evgeny Y. Khvorostinin, Ekaterina A. Odintsova, Taisia Y. Ekatova, Sergey E. Vinokurov, Vasily V. Zhigarev, Daniil A. Vetugov, Boris F. Myasoedov. Micro-sized particles of bentonite clays as perspective carriers of therapeutic radionuclides for nuclear medicine purposes. Journal of Radioanalytical and Nuclear Chemistry 2025; 334(10) doi: 10.1007/s10967-025-10442-2
|